COVID-19 infection has an impact on the mental state of patients and requires attention to mental health care. The aim of this study is to assess the effect of Yoga-based breathing practices on the mental state of patients with COVID-19. A randomized controlled trial was conducted with63 patients (male=46) who were RT-PCR positive for COVID-19 and hospitalized with asymptomatic (RT-PCR positive but no symptoms), mild (febrile, body ache, pharyngitis, nonproductive cough), and moderate (SpO2< 92%) symptoms assigned in the yoga (n=32) and control group (n=31). The study was conducted at Atharva Multispecialty Hospital and Research Center, North India. The yoga group received Yoga-based breathing practices twice a day for ten days in addition to conventional care, and the control group was advised not to do the practice. The Depression Anxiety and Stress scale (DASS-21) and fear of COVID-19 were assessed at baseline and after 10 days. Repeated measures ANOVA with Bonferroni correction was used to assess between and within subjects' effects. The experimental group had better scores for depression, anxiety, stress, total DASS scores, and fear of COVID-19 (p<0.001) when compared with the control group. Within the group, analyses demonstrated improved scores in all domains in the yoga group (p<0.001) by the end of the intervention. In contrast, the control group improved only in stress scores (p=0.002), total DASS scores (p=0.012), and fear of COVID-19 (p=0.039). There are no adverse effects seen with Yoga-based breathing practices in these patients. Yoga-based breathing practices have been found to have positive impact on mental health among COVID-19-positive patients during hospitalization. CTRI/2022/03/041071 Clinical Trials-Registry in India.
Background: Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder affecting 5%–10% of the global population and is characterized by recurrent abdominal pain and dysregulation of bowel movements. Many patients do not benefit from full remission of symptoms by conventional treatments. Recently, yoga has demonstrated its potential benefits in various medical conditions including IBS, as a result of its effect on the gut‐brain axis. This systematic review evaluates the effectiveness of yoga for the management of IBS. Methods: We conducted a comprehensive literature search in PubMed and Scopus until March 2025 to identify studies on yogic posture, pranayama, and meditation in IBS. After excluding reviews, case reports, and studies not meeting age or design criteria, 10 studies were included. These were evaluated for methodological quality and classified as randomized controlled trials (RCTs) or non‐controlled trials. We analyzed outcomes related to gastrointestinal symptoms, quality of life, and psychological symptoms and examined the type of yoga administered. Results: Yoga interventions led to amelioration of gastrointestinal symptoms, decreased anxiety and depression, and enhanced quality of life compared to usual care or wait‐list controls. Of note, the studies that fixed the change in the IBS Symptom Severity Scale scores as the primary outcome showed a moderate‐large effect of yoga on the improvement of symptoms compared to controls (Cohen's d range: 0.37–3.60). Conclusion: These preliminary findings suggest that yoga could favorably influence both the physical and psychological aspects of IBS. However, high‐quality larger sample studies are needed to confirm the findings reported in the review.
Yogic meditation, involving focused awareness, is gaining scientific attention for its impact on brain function and neurochemical balance. It enhances autonomic control and influences neurotransmitters related to emotional and cognitive health. This narrative review explored scientific studies on the effects of yogic meditation on EEG patterns and neurotransmitter levels. 21 peer-reviewed articles were selected through a structured search of PubMed, PubMed Central, and Google Scholar. The findings indicate that yogic meditation promotes coherent brainwave activity and modulates neurotransmitters, such as gamma-aminobutyric acid, thereby reducing anxiety, improving emotional regulation, and providing pain relief and autonomic stability. The studies literature suggest that yogic meditation may enhance brain function and emotional well-being, but these findings remain preliminary and require more well-designed confirmation.
8 March 2026 in Complementary Therapies in Medicine
Epilepsy is a chronic neurological disorder characterized by altered cortical excitability. The disorder is often associated with psychological distress and reduced quality of life. The purpose of the present review is to critically summarize the evidence on the effectiveness of meditation-based interventions for people with epilepsy. A comprehensive search was conducted in PubMed, Scopus, and Web of Science for articles published in English between January 2020 and May 2025. Five studies met the inclusion criteria (two randomized controlled trials, two open-label studies and one case report). Most studies reported significant improvements in depression, anxiety, concentration and quality of life following meditation interventions. Neurophysiological investigations demonstrated modulation of gamma power, beta burst duration, and interictal epileptiform discharges, suggesting a potential stabilizing effect on neural networks. However, evidence regarding seizure frequency reduction was inconsistent and generally not statistically significant. Meditation appears to be a promising adjunctive therapy for improving psychological well-being and potentially modulating cortical excitability in epilepsy. Future well-powered randomized controlled trials with standardized protocols and longer follow-up are warranted to confirm these findings and explore effects on seizure control.
2 July 2025 in European Journal of Integrative Medicine